Listed and unlisted equity investments

Hong Kong IPO disclosure precedents · 39 companies, 39 items

Listed shares, unlisted equity investments and investment funds held at fair value, including valuation of such investment portfolios.

2026-09-21Prospectus
Red Avenue New Materials Group Co., Ltd.彤程新材料集团股份有限公司09607.HK

For FY2023, FY2024, FY2025 and 6M2026, we registered a fair value gain of approximately RMB12.1 million, gain of RMB1.8 million, loss of RMB6.0 million and loss of RMB12.4 million on financial assets at fair value through profit or loss, respectively.

Financial Information · p. 211

As stipulated in our Policy on Management of External Investments (對外投資管理制度), external investments, including investments in financial assets at fair value through profit or loss, shall only be made if they are in line with our long-term development plan and strategy, favourable to expansion of our principal business, conducive to our sustainable development, with real prospects of generating returns and capable of improving our overall economic interests.

Financial Information · p. 234
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-21Prospectus
Shenzhen Kinwong Electronic Co., Ltd.深圳市景旺电子股份有限公司03228.HK

The wealth management products were mandatorily classified as financial assets at fair value through profit or loss as their contractual cash flows are not solely payments of principal and interest.

Financial Information · p. 231

Our investments in wealth management products will be subject to, and are expected to comply with, the Chapter 14 of the Listing Rules after the Listing.

Financial Information · p. 231

Our financial assets at fair value through profit or loss further decreased by RMB99.6 million, or 44.8%, to RMB122.6 million as of April 30, 2026, primarily due to the decrease in listed equity investments at fair value from RMB182.2 million as of December 31, 2025 to RMB82.6 million as of April 30, 2026.

Financial Information · p. 231
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-18Application Proof
Zhejiang Jingxin Pharmaceutical Co., Ltd.浙江京新药业股份有限公司

We recorded financial assets at FVTPL of RMB700.7 million, RMB1,322.2 million, RMB822.1 million and RMB1,115.7 million as of December 31, 2023 and 2024 and 2025 and the six months ended June 30, 2026.

Financial Information · p. 231

We recorded net other losses of RMB26.9 million in 2024 and net other gains of RMB18.1 million in 2025, primarily due to a change in fair value changes on financial assets at fair value through profit or loss from a loss of RMB42.4 million to a gain of RMB9.5 million, mainly attributable to the change in the fair value of our unlisted investee companies.

Financial Information · p. 221

Our investment policies for financial assets at FVTPL aims to preserve capital, maintain adequate liquidity and generate reasonable returns while managing investment risks, while our strategic equity investments target opportunities in cardiovascular and cerebrovascular diseases and CNS disorders that may support our R&D and market expansion.

Financial Information · p. 232
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-31Prospectus
Shenzhen Longsys Electronics Co., Ltd.深圳市江波龙电子股份有限公司09976.HK

We had financial assets at fair value through profit or loss (including both current and non-current portions) of RMB393.9 million, RMB899.7 million, RMB950.1 million and RMB1,068.1 million as of December 31, 2023, 2024, 2025 and April 30, 2026, respectively, consisting of current portion of nil, RMB179.6 million, RMB38.5 million and RMB2.8 million as of the same respective dates and non-current portion of RMB393.9 million, RMB720.1 million, RMB911.5 million and RMB1,065.3 million as of the same respective dates.

Financial Information · p. 258

We follow a prudent investment approach for wealth management products, focusing on capital preservation and stable returns.

Financial Information · p. 259
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-28Application Proof
Zhejiang Chint Electrics Co., Ltd.浙江正泰电器股份有限公司

For the six months ended June 30, 2026, gains on financial instruments at FVTPL primarily comprised disposal gains of RMB359.3 million and fair value gains of RMB158.4 million arising from Level 1 financial instruments measured at FVTPL.

Financial Information · p. 171

(1) an increase in gains on financial instruments at FVTPL from RMB12.5 million to RMB517.7 million, mainly reflecting changes in the fair value of our listed equity investments and (2) a decrease in asset impairment provision from RMB85.4 million to RMB6.4 million.

Financial Information · p. 177

(2) higher gains on financial instruments at FVTPL from RMB200.8 million in 2024 to RMB344.0 million in 2025, primarily reflecting changes in the fair value of derivative financial instruments, and (3) a decrease in asset impairment provision from RMB230.4 million in 2024 to RMB129.1 million in 2025.

Financial Information · p. 180
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-30Application Proof
YUEN KEE FOOD GROUP CO., LTD.袁记食品集团股份有限公司

Our financial investments at fair value through profit or loss (non-current) increased by 51.4% from RMB33.3 million as of December 31, 2024 to RMB50.4 million as of December 31, 2025 and further by 47.0% to RMB74.1 million as of May 31, 2026, primarily because of the increase in the fair value of our investments.

Financial Information · p. 212

We had a balance of RMB400.3 million of financial investments at fair value through profit or loss (current), representing wealth management products we purchased in 2026 and were holding as of the date indicated.

Financial Information · p. 218

Specifically, we are only allowed by our internal policies and guidelines to invest in structured deposits or certificates of deposit that carry low risk labels, with a term of no more than three months.

Financial Information · p. 214
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-22Prospectus
ZHONGJI INNOLIGHT CO., LTD.中际旭创股份有限公司03308.HK

Our financial assets at fair value through profit or loss increased from RMB784.3 million as of December 31, 2023 to RMB1,033.0 million as of December 31, 2024, primarily attributable to (i) an increase in investment in private equity funds of RMB178.8 million and

Financial Information · p. 256

We adopt a prudent investment policy with capital preservation and liquidity as our primary objectives, and only invest in wealth management products with high safety, strong liquidity, controllable risks and principal protection features.

Financial Information · p. 256
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-29Application Proof
Beijing Shengjing Wanglian Science and Technology Service Co., Ltd.北京盛景网联科技服务股份有限公司

The valuation of our funds and portfolio companies involves exercise of professional judgement and the use of certain bases, assumptions and unobservable inputs.

Financial Information · p. 205

Changes in these unobservable inputs caused by the capital market conditions and trends will affect the estimated fair value of our financial assets at fair value through profit or loss, which leads to uncertainty in our financial results.

Financial Information · p. 205
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-15Prospectus
Shanghai Seer Intelligent Technology Co., Ltd.上海仙工智能科技股份有限公司06106.HK

As of December 31, 2023, 2024 and 2025, we recorded financial assets at fair value through profit or loss of nil, RMB2.1 million and RMB18.0 million, respectively.

Financial Information · p. 236

We have adopted written policies and internal control procedures governing our wealth management product investments.

Financial Information · p. 236
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-12Application Proof
NINGBO SANXING MEDICAL ELECTRIC CO., LTD.宁波三星医疗电气股份有限公司

Our non-current financial assets at FVTPL amounted to RMB952.1 million, RMB756.4 million and RMB939.1 million as of December 31, 2023, 2024 and 2025, respectively.

Financial Information · p. 215

The decrease from 2023 to 2024 was primarily due to negative fair value changes in our unlisted equity investment portfolio, which subsequently recovered in 2025.

Financial Information · p. 215

Our current financial assets at FVTPL amounted to RMB53.7 million, RMB829.6 million and RMB564.2 million as of December 31, 2023, 2024 and 2025, respectively, with the fluctuation primarily reflecting changes in our purchases and redemptions of bank wealth management products for short-term cash management purposes.

Financial Information · p. 215
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-22Application Proof
Puxiang Healthcare Holding Limited普祥健康控股有限公司

Our financial assets measured at fair value through profit or loss increased from RMB2.5 million as of December 31, 2023 to RMB3.5 million as of December 31, 2024, and further increased to RMB9.5 million as of December 31, 2025, as we acquired additional unlisted equity securities.

Financial Information · p. 239

We primarily invest in structured deposits with maturities generally ranging from one to three months.

Financial Information · p. 239

For strategic equity investments, we require a rigorous and comprehensive due diligence process conducted by our dedicated investment department, and such investments must be approved by our investment committee before execution.

Financial Information · p. 239
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-15Application Proof
Shenzhen ADTEK Technology Co., Ltd.深圳市爱德泰科技股份有限公司

Our financial assets measured at fair value through profit or loss amounted to RMB16.5 million, RMB89.6 million and RMB48.5 million as of December 31, 2023, 2024 and 2025, respectively. Such financial assets primarily consisted of financial assets measured at fair value through profit and loss and fund products.

Financial Information · p. 180

The increase in 2024 was mainly attributable to the Company’s deployment of fund products held in Hong Kong, resulting in a marked increase in the balance of financial assets measured at fair value through profit and loss.

Financial Information · p. 181
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-11Application Proof
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.深圳迈瑞生物医疗电子股份有限公司

Our financial assets at fair value through profit or loss then decreased to nil as of December 31, 2024, as a result of our disposal of the equity investments.

Financial Information · p. 251

We recorded financial assets at fair value through profit or loss of RMB250.5 million as of December 31, 2025, primarily associated with our investment in certain wealth management products.

Financial Information · p. 251

We have adopted comprehensive investment policies and procedures.

Financial Information · p. 251
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-27Application Proof
Guangzhou Ruoyuchen Technology Co., Ltd.广州若羽臣科技股份有限公司

Our other financial assets at fair value through profit or loss decreased from RMB39.4 million as of December 31, 2023 to RMB31.0 million as of December 31, 2024, and further to RMB28.4 million as of December 31, 2025, primarily due to (i) the disposal of certain investments in unlisted equity instrument, and (ii) the fair value losses arisen from such investments.

Financial Information · p. 202

The fluctuation was primarily due to the fair value losses on financial instruments in 2024, which mainly resulted from fair value losses from an investee ceasing operations by the end of 2024.

Financial Information · p. 200

Pursuant to our internal Investment Management Policy (《投資管理規定》), any financial asset investment is subject to feasibility analysis and risk assessment conducted by the business department together with the Board Office and the Finance Department.

Financial Information · p. 202
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-31Prospectus
OmniVision Integrated Circuits Group, Inc.豪威集成电路(集团)股份有限公司00501.HK

Our financial assets at FVPL mainly represent our investments in equity instruments.

Financial Information · p. 328

To monitor and control the investment risks in our financial assets at fair value through profit or loss, we have adopted a structured internal review mechanism to manage our investment and the Board or personnel designated by the Board closely supervise our decision process.

Financial Information · p. 328

Our investment strategy related to financial assets at fair value through profit or loss focuses on managing the financial risks by reasonably and conservatively matching the estimated return on assets to anticipated our operating cash needs, while generating desirable investment returns for the benefits of our shareholders.

Financial Information · p. 328
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-30Prospectus
Knowledge Atlas Technology Joint Stock Company Limited北京智谱华章科技股份有限公司02513.HK

During the Track Record Period, our changes in fair value of financial instruments measured at FVPL represented changes in fair value of (i) our equity investment of certain unlisted entities; and (ii) our investments of wealth management products. We recognized changes in fair value of financial instruments measured at FVPL of RMB6.0 million, RMB26.0 million, RMB66.3 million, RMB7.0 million and RMB9.8 million in 2022, 2023 and 2024, and for the six months ended June 30, 2024 and 2025, respectively.

Financial Information · p. 260

Changes in fair value of financial instruments measured at FVPL significantly increased from RMB26.0 million in 2023 to RMB66.3 million in 2024, primarily due to the increase in the fair value of some investee companies and our procurement of wealth management products.

Financial Information · p. 265
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-30Prospectus
Shanghai Iluvatar CoreX Semiconductor Co., Ltd.上海天数智芯半导体股份有限公司09903.HK

As part of our cash management policy, we purchase wealth management products to better utilize our idle cash without interfering with our business operations or capital expenditures.

Financial Information · p. 310

We have formulated policies setting out the approval process for the purchase of funds and wealth management products, and the responsible person/department for the enforcement of the policies.

Financial Information · p. 310

An increase/decrease of 1% in net asset value would result in a corresponding increase/decrease in the fair value of the investments by RMB0.4 million, RMB0.9 million, RMB1.0 million and RMB0.1 million as of December 31, 2022, 2023 and 2024 and June 30, 2025, respectively.

Financial Information · p. 310
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-09Prospectus

Our financial assets at fair value through profit or loss including current and non-current components, represent our investment in funds and a U.S. licensed digital asset company.

Financial Information · p. 446

Our non-current financial assets at fair value through profit or loss decreased from HK$447.6 million as of December 31, 2023 to HK$388.4 million as of December 31, 2024, attributed to the decrease of unlisted investment — common share from HK$447.6 million as of December 31, 2023 to HK$388.4 million as of December 31, 2024, mainly due to the fair value change driven by the portfolio's subsequent financing activities.

Financial Information · p. 447

No more than 50% of the portfolio may be invested in any single instrument type in general, excluding government securities and bank deposits.

Financial Information · p. 448
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-12-03Prospectus
JINGDONG Industrials, Inc.京东工业股份有限公司07618.HK

Our fair value losses on equity investments in unlisted entities were RMB46.1 million, RMB78.4 million, RMB159.3 million, RMB134.8 million and RMB26.2 million in 2022, 2023 and 2024 and in the six months ended June 30, 2024 and 2025, respectively.

Financial Information · p. 321

We invested in these unlisted companies that are complementary to our existing business in order to enhance our competitive position and improve our long-term profitability.

Financial Information · p. 338
The company's explanation, the adviser's view and the page in the filing: see Matters
2025-10-28Prospectus
Pony AI Inc.小马智行02026.HK

We recorded other expense — net, of US$15.5 million in 2024, as compared to other income — net of US$1.4 million in 2023, primarily attributable to fair value changes of our equity securities investments.

Financial Information · p. 512

We recorded other expense — net, of US$2.0 million for the six months ended June 30, 2025, as compared to other income — net of US$3.0 million for the six months ended June 30, 2024, primarily attributable to fair value changes of our equity securities investments and foreign exchange gains (losses).

Financial Information · p. 512

Accordingly, the reconciliation includes an expense recognition difference in the consolidated statements of profit or loss and other comprehensive income of US$3.2 million, US$8.1 million, US$16.1 million, US$5.2 million and US$13.8 million for the years ended December 31, 2022, 2023 and 2024 and the six months ended June 30, 2024 and 2025, respectively.

Financial Information · p. 551
The company's explanation, the adviser's view and the page in the filing: see Matters
1 / 2

Tell us